Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis.

Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis.
复制标题

所有肺动脉高压组的当代风险评分比较 - PVRI GoDeep 元注册分析。

DOI:
10.1016/j.chest.2024.03.018
复制
发表时间:
2024
期刊:
影响因子:
9.6
通讯作者:
Arvanitak
Arvanitak
中科院分区:
医学1区
文献类型:
--
作者:
Yogeswaran,Athiththan;Gall,Henning;Fünderich,Meike;Wilkins,MartinR;Howard,Luke;Kiely,DavidG;Lawrie,Allan;Hassoun,PaulM;Sirenklo,Yuriy;Torbas,Olena;Sweatt,AndrewJ;Zamanian,RohamT;Williams,PaulG;Frauendorf,Marlize;Arvanitak

文献摘要

相似文献

背景:肺动脉高压是一种异质性疾病,预后差。准确的危险分层对于指导肺动脉高压(PAH)的治疗决策至关重要。虽然已经开发了各种PAH的风险模型,但它们的相对预后潜力还需要进一步探索。此外,风险评分在组1以外的PH组中的适用性仍有待调查。
BackgroundPulmonary hypertension (PH) is a heterogeneous disease with poor prognosis. Accurate risk stratification is essential for guiding treatment decisions in pulmonary arterial hypertension (PAH). While various risk models were developed for PAH, their comparative prognostic potential requires further exploration. Additionally, the applicability of risk scores in PH groups beyond group 1 remains to be investigated.